Accelerating Drug Development through Adaptive Design with SVP Global Development at Amgen

January 26 2021, 5:30 PM - 6:30 PM EST

Tuesday, January 26th
5:30 PM EST

To Be Announced


Please join YJP and, Elliott Levy, M.D., Senior Vice President, R&D Strategy and Operations at Amgen on January 26th at 5:30pm ET as we discuss accelerating Drug Development through Adaptive Design.

Through this mentorship initiative, young professionals will have the opportunity to explore innovative strategies to set your career goals for 2021. Our virtual community will have the opportunity to partake in an intimate and candid discussion with a Q&A session.      

For questions about the event: please email

*YJP has a non-solicitation policy covering all of our conferences and events. In order to provide a distraction-free environment for our mentors, sponsors, attendees, and employees, we do not allow solicitation at our events by attendees or unauthorized parties without the express written permission or consent from YJP. 

05b14c0355dae621522d877b8edd7b4215dbeca1 large
Elliott M. Levy, M.D.
Senior Vice President, R&D Strategy and Operations at Amgen

Elliott M. Levy, M.D., is senior vice president, R&D Strategy and Operations, responsible for delivering the operational and transformational capabilities essential to executing Amgen’s R&D strategy. Levy joined Amgen in 2014 and was senior vice president, Global Development, responsible for the clinical
development of Amgen’s pipeline.

Before joining Amgen, Levy served as senior vice president and head of Specialty Development at Bristol-Myers Squibb (BMS). Prior to that role, he held the position of senior vice president of Global Pharmacovigilance and Epidemiology. Levy joined BMS in 1997 and during his 17 years at the company, he held a range of senior positions in cardiovascular clinical development, immunoscience clinical research, and global clinical research operations.

Prior to BMS, Levy was a member of the Renal Division at Brigham and Women's Hospital in Boston, Massachusetts, where he was an investigator in federally sponsored outcomes research as well as industry-sponsored clinical trials.

B968ff67a149e7968ef11dfb27e22417b98f9b87 large
Geoffrey Spolyar
Special Counsel at Cooley

Geoffrey Spolyar focuses his practice on the representation of life sciences companies in a broad range of commercial and financial matters. Much of his practice is devoted to negotiating and drafting corporate partnership agreements, licensing arrangements, strategic alliances, joint venture agreements and other complex technology transactions. Prior to joining Cooley, Geoffrey was senior counsel at Amgen in Thousand Oaks, California where he represented Amgen in a number of strategic alliances including its joint venture with Astellas Pharma in Japan and its collaboration with AstraZeneca regarding several of Amgen’s inflammation programs.


Partial Guest List

Users photos missing
Ca6b5bea4660903d3374038e8599c24e4c1e906b thumb
37144d6d3542473ffc32e6cd34c4c551de3afd54 thumb
74fb786c4ac3767bf01a6e494452a4f4da6b4550 thumb
E3a3a37f441ee726cdbe6383195f6860b947b069 thumb
Users photos missing
Users photos missing
Users photos missing
Users photos missing
3049b5790359ba6ebe938870bd67ef4dda17f5a7 thumb
4fa1fe35ce4344d0c04045b4074c554e1db9220e thumb
006c1c1471796f40257bd8ce5d0c52c9c4341d91 thumb
B5a9d810d3b36334f69be2c88c2cc6e9a249c069 thumb
E291fe21950c6adb797413dba7af5ff91a0e4dfb thumb
1d22d9097b398ba8bc9d4b4f6c18f444b9fa4e3d thumb
Dc91ff123e49e27c0d0398e0054f0fa23b4cf81c thumb
0c5ce8bec66dc41834af313d14015ea58b6ae2b1 thumb
626b8327ff299a169d9d9a6efae04be7220be4d4 thumb
Cfa0bcc9cfc11d0fbdbb4ac193259d1244ef0e36 thumb
D8fd9ae8586dfd7ce0f5d10e1bf80f25703b3244 thumb
Users photos missing
19c6a496d01abaa5d3c5eb6043f53bd52d14bbd7 thumb
C3d115da19c50d6b9f04d8122e45ac62b9d5bec9 thumb
818442624d8577a0b3f38e1bd87240feae872595 thumb
797f6f5bbcce6e298d6bd6c79315766c9c68cc6e thumb
Event Over
This event has concluded.